Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Intelsius Celebrates 15 Years of Protecting Life’s Most Precious Cargo™

Published: Monday, January 28, 2013
Last Updated: Sunday, January 27, 2013
Bookmark and Share
Company announces launch of 15th Anniversary Celebration year.

Intelsius has announced the launch of its 15th Anniversary Celebration year.

“We are delighted to announce this milestone and intend to make it our most successful year ever,” said founder David Walsh, chief executive officer of Intelsius.

Walsh continued, “The answer to one problem created a new company that began making temperature controlled, regulatory compliant packaging 15 years ago and continues to create innovative solutions today.”

Intelsius was incorporated as DGP Group in 1998, when the company developed a unique packaging solution designed for the transportation of samples suspected of containing the BSE (Bovine Spongiform Encephalitis, or “Mad Cow Disease”) prion.

Within one year DGP Group commercialized the first UN-certified TSE/BSE sample shipper in the world.

The company, rebranded as Intelsius in 2010, has grown from three partners and expanded with offices and manufacturing facilities throughout the world including Europe, North America and Asia.

Intelsius now serves a wide range of organizations, including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries, to major laboratories.

Intelsius temperature-controlled packaging systems (-70ºC, -20ºC, 2-8ºC and 15-25 ºC) meet or exceed WHO, ISTA, IATA perishable goods and USP1079 standards.

In addition, where applicable, they comply with UN dangerous goods regulatory performance requirements.

Intelsius, at the cutting edge of temperature control technology, maintains an ISTA-certified laboratory and has hundreds of innovative solutions to its credit.

All Intelsius products are supported by proprietary temperature and excursion risk assessment software; ATMOS.

“Intelsius will continue to push the design envelope, developing solutions and technological services unavailable elsewhere in the temperature-controlled packaging industry,” said Walsh.

Walsh continued, “Patient safety has always been at the forefront of our minds, these last 15 years. This is a great opportunity to renew our commitment to listening to our clients, being responsive to their needs, and ultimately striving to anticipate their needs before they arise.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Skin Cells Turned into Heart Cells and Brain Cells Using Drugs
In a scientific first, Gladstone researchers have used chemical drugs to convert skin cells into heart cells and brain cells, without adding any external genes.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
‘Mini-Brains’ to Study Zika
Novel tool expected to speed research on brain and drug development.
Cytokine Triggers Immune Response at Expense of Blood Renewal
Research highlights promise of Anti-IL-1 drugs to treat chronic inflammatory disease.
AstraZeneca to Sequence 2 Million Genomes in Search for New Drugs
Company launches integrated genomics approach which aims to transform drug discovery and development.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
Micro Heart Muscle Created from Stem Cells
Researchers have designed a new way to create micro heart muscle from stem cells using a unique dog bone dish.
Immune Booster Tested in Advanced Merkel Cell Cancer
The immunotherapy drug produced durable responses in many patients.
Mutated Mitochondria Found in Stem Cells
Researchers find hidden genetic mutations in patient-derived stem cells which could ultimately undermine therapeutic benefit.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!